• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SATB2、ISL1 和 TTF1 在鉴别直肠来源与其他胃肠道和肺的高分化神经内分泌肿瘤中的价值。

Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.

机构信息

Department of Pathology, Daping Hospital and Research Institute of Surgery, Army Military Medical University (Army Special Medical Center), Chongqing, China.

Cancer Center, Daping Hospital and Research Institute of Surgery, Army Military Medical University (Army Medical Center of PLA), Chongqing, China.

出版信息

Pathol Res Pract. 2019 Jul;215(7):152448. doi: 10.1016/j.prp.2019.152448. Epub 2019 May 18.

DOI:10.1016/j.prp.2019.152448
PMID:31133441
Abstract

BACKGROUND

Management of neuroendocrine tumors (NETs) depends on the primary site, but the location of many well-differentiated (WD) NETs is elusive. Organ-specific markers are required for pathological diagnosis from biopsy. Transcription factors with good organ specificity include TTF1 (thyroid transcription factor 1; lung), CDX2 (caudal type homeobox transcription factor 2; midgut), and ISL1 (ISL LIM homeobox 1) and PAX8 (paired box 8) for the pancreas and rectum. SATB2 (SATB homeobox 2) has shown high sensitivity and specificity in colorectal adenocarcinoma. This study determined the viability of SATB2 and other transcription factors as markers, single or in combination, for WD-NETs of various sites.

METHODS

Immunohistochemical staining of 81 WD-NETs from 8 organ sites was performed to identify SATB2, TTF1, CDX2, ISL1, and PAX8. Receiver operating characteristic (ROC) curves were constructed for different combinations of the 5 markers to determine sensitivity and specificity.

RESULTS

Among the WD-NETs, SATB2 was predominantly found in those of the rectum; TTF1 in the lung, larynx, and esophagus; and ISL1 in the duodenum and rectum. PAX8 and CDX2 showed poor organ specificity. ROC profiles showed 50% sensitivity and 96% specificity to lung for TTF1 ISL1-; and 65% sensitivity and 100% specificity to rectum for SATB2 ISL1- TTF1-. ISL1 SATB2- TTF1- showed 83% sensitivity and 85% specificity to the duodenum, and 44% sensitivity and 87% specificity to the pancreas. A literature search showed that there was no significant difference in the expression rates of the five transcription factors (TTF1, CDX2, SATB2, PAX8 and ISL1) between primary and metastatic WD-NETs at the same organ when there was a large sample size.

CONCLUSION

Among the 5 transcription factors tested, SATB2 may be a viable marker of WE-NETs of the rectum. The combination of SATB2, ISL1, and TTF1 may help estimate the locations of WD-NETs of unknown origin.

摘要

背景

神经内分泌肿瘤(NETs)的治疗取决于肿瘤的原发部位,但许多分化良好(WD)NETs 的位置难以捉摸。从活检中进行病理诊断需要器官特异性标志物。具有良好器官特异性的转录因子包括甲状腺转录因子 1(TTF1;肺)、尾型同源盒转录因子 2(CDX2;中肠)、ISL1(ISL LIM 同源盒 1)和 PAX8(配对盒 8)用于胰腺和直肠。SATB2(SATB 同源盒 2)在结直肠腺癌中具有高灵敏度和特异性。本研究旨在确定 SATB2 和其他转录因子作为标志物的可行性,单独或联合用于各种部位的 WD-NETs。

方法

对 8 个器官部位的 81 例 WD-NETs 进行免疫组织化学染色,以鉴定 SATB2、TTF1、CDX2、ISL1 和 PAX8。为不同的 5 种标志物组合构建接收者操作特征(ROC)曲线,以确定敏感性和特异性。

结果

在 WD-NETs 中,SATB2 主要存在于直肠;TTF1 存在于肺、喉和食管;ISL1 存在于十二指肠和直肠。PAX8 和 CDX2 显示出较差的器官特异性。ROC 图谱显示 TTF1 ISL1-对肺的敏感性为 50%,特异性为 96%;SATB2 ISL1-对直肠的敏感性为 65%,特异性为 100%。ISL1 SATB2- TTF1-对十二指肠的敏感性为 83%,特异性为 85%;对胰腺的敏感性为 44%,特异性为 87%。文献检索显示,当样本量较大时,同一器官的原发性和转移性 WD-NETs 中五种转录因子(TTF1、CDX2、SATB2、PAX8 和 ISL1)的表达率无显著差异。

结论

在测试的 5 种转录因子中,SATB2 可能是直肠 WD-NETs 的可行标志物。SATB2、ISL1 和 TTF1 的组合可能有助于估计来源不明的 WD-NETs 的位置。

相似文献

1
Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.SATB2、ISL1 和 TTF1 在鉴别直肠来源与其他胃肠道和肺的高分化神经内分泌肿瘤中的价值。
Pathol Res Pract. 2019 Jul;215(7):152448. doi: 10.1016/j.prp.2019.152448. Epub 2019 May 18.
2
Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.SATB2 阳性可将 Islet1 阳性直肠神经内分泌肿瘤与胰十二指肠神经内分泌肿瘤区分开来。
J Clin Pathol. 2021 Sep;74(9):582-588. doi: 10.1136/jclinpath-2020-206645. Epub 2020 Sep 15.
3
SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.SATB2 在神经内分泌肿瘤中的表达:强表达仅限于分化较好的下消化道来源肿瘤,在低分化癌中最常见于 Merkel 细胞癌。
Histopathology. 2020 Jan;76(2):251-264. doi: 10.1111/his.13943. Epub 2019 Nov 15.
4
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.胰岛1(Isl1)表达是胰腺内分泌肿瘤及其转移的可靠标志物。
Am J Surg Pathol. 2008 Mar;32(3):420-5. doi: 10.1097/PAS.0b013e318158a397.
5
The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.74例低分化神经内分泌癌中TTF1、CDX2和ISL1的表达情况
Ann Diagn Pathol. 2018 Dec;37:30-34. doi: 10.1016/j.anndiagpath.2018.09.005. Epub 2018 Sep 13.
6
The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.直肠神经内分泌肿瘤中胰岛 1 和 PAX8 的免疫组化表达应考虑在不明原发灶转移性神经内分泌肿瘤的鉴别诊断中。
Endocr Pathol. 2013 Dec;24(4):184-90. doi: 10.1007/s12022-013-9264-9.
7
Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.肝转移性高分化神经内分泌肿瘤起源的免疫组化特征
Am J Surg Pathol. 2017 Jul;41(7):915-922. doi: 10.1097/PAS.0000000000000876.
8
Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.胰岛细胞 1 和 PAX8 在鉴定胰腺来源的转移性神经内分泌肿瘤中的价值。
Mod Pathol. 2012 Jun;25(6):893-901. doi: 10.1038/modpathol.2012.34. Epub 2012 Mar 2.
9
CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.在库肯勃瘤中 CDX2、SATB2、GATA3、TTF1 和 PAX8 的免疫组化染色。
Int J Gynecol Pathol. 2020 Mar;39(2):170-177. doi: 10.1097/PGP.0000000000000582.
10
An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.一种利用 CK7、TTF1、β-连环蛋白、CDX2 和 SSTR2A 的算法方法可有助于鉴别胃肠道和肺神经内分泌癌。
Virchows Arch. 2021 Sep;479(3):481-491. doi: 10.1007/s00428-021-03085-7. Epub 2021 Mar 17.

引用本文的文献

1
Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis.黄芪和丹参对特发性肺纤维化肌成纤维细胞激活干预的全基因组 DNA 甲基化分析。
BMC Pulm Med. 2023 Sep 4;23(1):325. doi: 10.1186/s12890-023-02601-6.
2
Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.HOXB13 在神经内分泌肿瘤中的免疫反应性是直肠高分化神经内分泌肿瘤的一个敏感且特异的标志物。
Endocr Pathol. 2023 Sep;34(3):333-341. doi: 10.1007/s12022-023-09779-9. Epub 2023 Aug 8.
3
Breast mass as the first sign of metastasis from rectal carcinoma: a case report and review of the literature.
以乳腺肿块为首发表现的直肠癌转移:1例病例报告并文献复习
Front Oncol. 2023 Jun 26;13:1211645. doi: 10.3389/fonc.2023.1211645. eCollection 2023.
4
Renal neuroendocrine tumors: clinical and molecular pathology with an emphasis on frequent association with ectopic Cushing syndrome.肾脏神经内分泌肿瘤:临床和分子病理学,重点是常与异位库欣综合征有关。
Virchows Arch. 2023 Oct;483(4):465-476. doi: 10.1007/s00428-023-03596-5. Epub 2023 Jul 5.
5
Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours.多灶性空肠回肠神经内分泌肿瘤瘤间异质性的频率及预后意义
Cancers (Basel). 2022 Aug 17;14(16):3963. doi: 10.3390/cancers14163963.
6
An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs.不同消化器官神经内分泌肿瘤的概念发展、诊断标准及挑战性问题的最新进展
Virchows Arch. 2022 Jun;480(6):1129-1148. doi: 10.1007/s00428-022-03306-7. Epub 2022 Mar 12.
7
Lung neuroendocrine tumors: A systematic literature review (Review).肺神经内分泌肿瘤:一项系统文献综述(综述)
Exp Ther Med. 2022 Feb;23(2):176. doi: 10.3892/etm.2021.11099. Epub 2021 Dec 28.
8
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.消化系统神经内分泌肿瘤的病理学报告:你一直想知道但又不敢问的一切。
Front Endocrinol (Lausanne). 2021 Apr 23;12:680305. doi: 10.3389/fendo.2021.680305. eCollection 2021.
9
Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.胃肠胰神经内分泌肿瘤:临床概述。
World J Gastrointest Surg. 2021 Mar 27;13(3):231-255. doi: 10.4240/wjgs.v13.i3.231.
10
Neuroendocrine neoplasms of the appendix, colon and rectum.阑尾、结肠和直肠的神经内分泌肿瘤。
Pathologica. 2021 Feb;113(1):19-27. doi: 10.32074/1591-951X-230.